Episode #9
[09] Ultime novità nello sviluppo di agenti antitumorali
May 25, 2026—S0
<p>Panoramica su nuove molecole e repurpusing di farmaci già approvati</p>
Loading…
Loading…
General
Hosted by Unknown Host · General · IT · 0 episodes
Questo podcast esplora il mondo della ricerca oncologica moderna e dello sviluppo di nuovi farmaci antitumorali, raccontando in modo accessibile ma scientificamente rigoroso come la scienza stia cambiando il modo di studiare e combattere il cancro. Attraverso gli episodi si affrontano temi chiave della chimica farmaceutica applicata all’oncologia, partendo dalle basi etiche della ricerca, come il principio delle 3R e il ruolo della sperimentazione animale ,fino alle tecnologie più avanzate che stanno rivoluzionando il settore. Si passa poi ai nuovi modelli sperimentali, come i modelli tumorali 3D e la biostampa (bioprinting), che permettono di ricreare il tumore in laboratorio in modo sempre più realistico, migliorando la sperimentazione dei farmaci e riducendo la dipendenza dagli animali. Il podcast approfondisce anche i meccanismi biologici e molecolari alla base del cancro, come l’epigenetica e i checkpoint immunitari (ad esempio PD-L1), spiegando come questi sistemi vengano sfruttati per sviluppare terapie più mirate. Ampio spazio è dedicato alle strategie terapeutiche innovative, tra cui anticorpi monoclonali, PROTACs e RIBOTACs, che rappresentano approcci di nuova generazione per distruggere selettivamente le cellule tumorali o interferire con i loro segnali vitali. Infine, gli episodi offrono uno sguardo aggiornato sulle ultime novità nello sviluppo di agenti antitumorali, mettendo in evidenza come la ricerca stia evolvendo verso terapie sempre più precise, personalizzate ed efficaci. Nel complesso, il podcast racconta l’incontro tra scienza, tecnologia ed etica nella lotta contro il cancro, mostrando quanto sia complesso ma anche promettente il futuro dell’oncologia.
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
36%
Guest openness
Selective
Sign up to generate a grounded pitch for Frontiere Innovative In Chimica Farmaceutica Oncologica.
Signup to Generate a PitchFrontiere Innovative In Chimica Farmaceutica Oncologica is a general podcast hosted by Unknown Host, with 0 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.
Unknown Host hosts Frontiere Innovative In Chimica Farmaceutica Oncologica, a general show with 0 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #9
<p>Panoramica su nuove molecole e repurpusing di farmaci già approvati</p>
Episode #8
<p>Descrizione, importanza e utilizzo in terapia</p>
Episode #7
<p>Descrizione, utilizzo ed esempi pratici in oncologia</p>
Episode #6
<p>RIBOTACs, descrizione, importanza e applicazioni</p>
Episode #5
<p>PROTACs, descrizione, importanza e applicazioni</p>
Sponsor detection runs nightly. Check back soon.
Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
